Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

Add to Watch List

Set Alert

0.655 Data as of May 17	-0.007 / -1.06% Today’s Change	0.45 Today\|\|\|52-Week Range 0.92	+14.91% Year-to-Date

0.655

Data as of May 17

-0.007 / -1.06%

Today’s Change

0.45

Today|||52-Week Range

0.92

+14.91%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$30.3M

Company Description

Mast Therapeutics, Inc. is a specialty pharmaceutical company which focuses on developing proprietary product candidates. Its lead product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has potential application in treating a wide range of diseases and conditions, such as complications arising from sickle cell disease. It is also developing ANX-514, a detergent-free formulation of the chemotherapy drug docetaxel. The company was founded in December 1995 and is headquartered in San Diego, CA.

Contact Information

Mast Therapeutics, Inc.

12390 El Camino Real

San Diego California 92130

P:(858) 552-0866

Investor Relations:

www.adventrx.com

Employees

Shareholders

Mutual fund holders	2.95%
Other institutional	10.22%
Individual stakeholders	--

Top Executives

Brian M. Culley, MBA, CPA	Chief Executive Officer & Director
Patrick L. Keran	President, Chief Operating Officer & Secretary
Brandi L. Roberts, MBA, CPA	CFO, CAO, Chief Medical Officer & SVP-Development
Santosh J. Vetticaden, MD, PhD	Chief Medical Officer & Senior Vice President
Robert Martin Emanuele, PhD, MBA	Senior Vice President-Development

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.